Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 9 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 4 - Drug target pathways : 5

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Lonafarnib
   Boston Children's Hospital
      2009   Phase 2   NCT00879034   United States
   Eiger BioPharmaceuticals
      2020   -   NCT03895528   -
   Monica E. Kleinman
      2007   Phase 2   NCT00425607   United States
   PRG Science & Technology Co., Ltd.
      2025   Phase 2   NCT06775041   United States
   The Children's Hospital Zhejiang University School of Medicine
      2021   -   ChiCTR2100050052   China
Lonafarnib, zoledronic acid, and pravastatin
   Boston Children's Hospital
      2009   Phase 2   NCT00916747   United States
Pravastatin
   Boston Children's Hospital
      2009   Phase 2   NCT00879034   United States
Progerinin
   PRG Science & Technology Co., Ltd.
      2025   Phase 2   NCT06775041   United States
      2020   Phase 1   NCT04512963   United States
Umbilical cord blood unit
   Bundang CHA Hospital
      2019   Phase 1/Phase 2   NCT03871972   Korea, Republic of
Zoledronic acid
   Boston Children's Hospital
      2009   Phase 2   NCT00879034   United States
Zoledronic acid, pravastatin
   Assistance Publique Hopitaux De Marseille
      2008   Phase 2   NCT00731016   France